Stacey Wood in Wichita, Kansas

Home Kansas Wichita

Stacey Wood has Nurse Practitioner as her primary medical specialty. Their primary office is: 2300 N Tyler Rd in Wichita, Kansas. There are 2 additional office locations for Stacey Wood that can be viewed towards the end of their profile.

They're a part of the: Legacy Healthcare Services Inc medical group which has around 2,617 members. You can call their office at 316-260-6161 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2020 (around 4 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Stacey Lynn Wood Office Phone and Directions

Stacey Wood
Legacy Healthcare Services Inc
2300 N Tyler Rd
Wichita, Kansas 67205
316-260-6161

Patient Ratings
Please rate your experience with Stacey Wood below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 316-260-6161

Enter a starting address:

Healthcare Info for Stacey Wood

Medical School: Sorry, her university is not listed
Graduation Year: 2020
The Primary Medical Specialty for Stacey Wood is listed as: Nurse Practitioner
Approximate Years of Experience: 4
PAC (PECOS ID)#: 0042608929
NPI #: 1396320958
NPI Created On: 03/16/2021
NPI Last Updated Listed as: 09/08/2023
Primary Taxonomy Code: 363LF0000X
License Number:
53-79878-011
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788190291

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30